Vimian Group

36.26

SEK

+0.89 %

Less than 1K followers

VIMIAN

NASDAQ Stockholm

Health Care Providers

Health Care

Overview

Ownership

Investor consensus

+0.89%

-10.69%

-9.8%

-8.89%

-19.96%

+23.33%

-38.31%

-

-53.71%

Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.

Market cap

19B SEK

Turnover

7.38M SEK

Revenue

4.3B

EBIT %

13.13 %

P/E

79.04

Dividend yield-%

-

Financial calendar

29/4

2025

Interim report Q1'25

29/4

2025

General meeting '25

18/7

2025

Interim report Q2'25

All

Webcasts

Press releases

ShowingAll content types

Vimian Group, Audiocast with teleconference, Q1'25

Webcast4/29/2025, 7:00 AM

Vimian Group, Audiocast with teleconference, Q1'25

Regulatory press release38 minutes ago

Vimian’s Interim Report for the first quarter of 2025

Regulatory press release38 minutes ago

Vimians delårsrapport för det första kvartalet 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release22 hours ago

Finansinspektionen: Flaggningsmeddelande i Vimian Group AB

Press release4/25/2025, 1:15 PM

Invitation to Vimian’s Interim Report for the first quarter of 2025

Press release4/25/2025, 1:15 PM

Inbjudan till Vimians delårsrapport för det första kvartalet 2025

Regulatory press release4/24/2025, 6:45 AM

Finansinspektionen: Flaggningsmeddelande i Vimian Group AB

Regulatory press release4/4/2025, 2:30 PM

Vimian Group AB (publ) avslutar avtal om likviditetsgaranti

Regulatory press release4/4/2025, 2:30 PM

Vimian Group AB (publ) terminates liquidity guarantee agreement

Regulatory press release4/1/2025, 11:47 AM

Finansinspektionen: Flaggningsmeddelande i Vimian Group AB

Nasdaq, Vimian Group, 2025

Webcast3/28/2025, 7:45 AM

Nasdaq, Vimian Group, 2025

Regulatory press release3/28/2025, 7:30 AM

Notice of Annual General Meeting in Vimian Group AB (publ)

Regulatory press release3/28/2025, 7:30 AM

Kallelse till årsstämma i Vimian Group AB (publ)

Regulatory press release3/28/2025, 6:30 AM

Trading in Vimian Group AB (publ)’s ordinary shares on Nasdaq Stockholm commences today

Regulatory press release3/28/2025, 6:30 AM

Handeln i Vimian Group (publ):s stamaktier inleds idag på Nasdaq Stockholm

Regulatory press release3/21/2025, 10:15 AM

Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market

Regulatory press release3/21/2025, 10:15 AM

Vimian Group AB (publ) offentliggör prospekt i samband med notering på Nasdaq Stockholms huvudlista

Regulatory press release3/19/2025, 7:00 AM

Vimian’s Nomination Committee proposes Pia Marions as new Board member

Regulatory press release3/19/2025, 7:00 AM

Vimians valberedning föreslår Pia Marions som ny styrelseledamot

Regulatory press release3/14/2025, 2:35 PM

Vimian has been approved for listing on Nasdaq Stockholm

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.